Leading the Way in Life Science Technologies

GEN Exclusives

More »

April 15, Vol. 33, No. 8

  • Feature Articles

    • Exploring GPCRs as Therapeutic Targets
    • Caitlin Smith
    • Recent years have seen an explosion of disease-relevant research on G-protein coupled receptors (GPCRs) Hot topics include strategies for targeting GPCRs therapeutically, and understanding the mechanisms of biased agonism A number of distinguished speakers will present their latest GPCR research ... more »
    • Boosting Downstream Productivity
    • MaryAnn Labant
    • In 2012, BioPlan Associates estimated the global market for biopharmaceuticals at $140 billion, of which $100 billion was for recombinant proteins The monoclonal antibody (mAb) market, a subclass of recombinant proteins, was estimated at $40 billion... more »
    • Stockholm-Uppsala Region Ups the Ante
    • Tamlyn Oliver
    • Putting neighboring-city rivalries aside, government agencies and the life science communities in Stockholm and Uppsala, Sweden, have joined forces with plans to create an internationally renowned life science cluster The region is boldly ambitious Its ultimate goal is a position ... more »
    • Single-Use Bioreactor Roundup
    • A number of bioprocess analysts estimate that the entire single-use market has been growing at about 15–20% per year Single-use bioreactors (SUB), in particular, are rapidly increasing in popularity and seem destined to stay GEN polled a number of leading ... more »
  • Columns

    • People in the News
    • Conkwest hired Hans Klingemann, MD, PhD , as CMO and CSO Dr Klingemann is a member of the board for Osiris Therapeutics Previously, he was professor of medicine and director, bone marrow and stem cell transplant program at Tufts Medical ... more »
    • Exosome Research Publication Landscape
    • Gary Oosta
      Jeff Fan
    • Exosome research is growing exponentially as researchers from several disparate disciplines are exploring the role of exosomes in inter-cellular communication, immunological responses, stem cell behavior, cancer cell communication, etc Indeed, the potential of exosomes and other classes of microvesicles as ... more »
    • Cytomics for Personalized Heart Health
    • Carol Potera
    • CytoVas aims to improve the assessment of cardiovascular health The early-stage, in vitro diagnostic company is working to improve its Vascular Health Profile (VHP) Based on cytomics, which analyzes cell systems and networks, VHP is a blood test that gives ... more »
    • Advertorial: AAIPharma Services
    • AAIPharma Services is a highly experienced provider of drug development, manufacturing, and analytical services to the pharmaceutical, biotech, and healthcare industries For over 33 years, AAIPharma has been a leading provider and has grown into a one-stop contract development and ... more »
    • Advertorial: ACEA Biosciences
    • The year 2013 marks a significant milestone for ACEA Biosciences as the company celebrates its 10th anniversary Over the course of the last decade ACEA has transformed itself from a small startup company to a leading provider of instrumentation for ... more »